Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sarepta Therapeutics (NQ: SRPT )

98.24 USD +1.32 (+1.36%)
Official Closing Price Updated: 7:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,445,600
Open 95.76
Bid (Size) 97.50 (4)
Ask (Size) 97.90 (1)
Prev. Close 96.92
Today's Range 95.45 - 98.79
52wk Range 78.06 - 181.83
Shares Outstanding 65,531,046
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics
From GlobeNewswire News Releases
Sarepta Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
From GlobeNewswire News Releases

Performance

YTD
-40.57%
-40.57%
1 Month
-43.87%
-43.87%
3 Month
-29.13%
-29.13%
6 Month
-38.00%
-38.00%
1 Year
-12.59%
-12.59%

More News

Read More
SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm
From GlobeNewswire News Releases
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From Business Wire News Releases
SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Fir
From PR Newswire
Noteworthy Wednesday Option Activity: CALX, CCS, SRPT
Tags Stocks
From Market News Video
Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine?
From Investor's Business Daily
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
From Business Wire News Releases
NASDAQ:SRPT Shareholder Notice: Investigation over Potential Securities Laws Violations by Sarepta Therapeutics, Inc.
From SBWire - Latest Press Releases
The Week Ahead In Biotech (Jan 10-16): Expect Stocks To Move As J.P. Morgan Healthcare Conference Kicks Off
Tags AVEO SCPS Penny Stocks
From Benzinga
Here's Why Sarepta Therapeutics Lost Support on Wall Street
Tags RHHBY JPM Market News
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.